ATR
AptarGroup, Inc.
Healthcare · Medical Instruments & Supplies · NYQ
$113.36
Data: 2026-05-28
✓ ETHICAL PASS

Unknown MOAT
HIGH
Data Confidence: 100.0%
Key Metrics

How this company measures up on the fundamentals that matter

Market Cap
$7.4B
Total market value of the company
19.71
Reasonably valued
18.38
Based on estimated future earnings — lower means cheaper
Rev Growth
+10.8%
Year-over-year revenue change
Profit Margin
10.0%
How much profit the company keeps from each dollar of revenue
14.8%
Return on equity — how efficiently it uses shareholder money
Analyst Target
$156.00
+38% from current price — median analyst estimate
Recommendation
NONE
Consensus view from 7 analysts covering this stock
About AptarGroup, Inc.

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

https://www.aptar.com

Country: United States Employees: 14,000 Industry: Medical Instruments & Supplies
Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
0.0% N/A
Debt must be below 33% of total assets
Cash Ratio
0.0% N/A
Interest-bearing cash below 33% of assets
Receivables
0.0% N/A
Receivables below 49% of assets
Revenue Purity
0.0% PASS
Non-compliant revenue below 5% — any excess requires purification
Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

DISTRIBUTION
Smart money appears to be selling into strength — caution
-0.296
Returns do not compensate for the risk — negative edge
-0.0347
No positive edge detected — the data suggests staying out
-0.269
Drawdown risk outweighs the returns — higher risk profile
Annual Return
-9.4%
Historical annualised return based on price data
-35.0%
Largest peak-to-trough decline — the worst it has been
BEAR
Statistical model detects bearish conditions
Days in State
6
How long the current regime has persisted — longer means more stable
Market Data

Trading characteristics and market positioning

0.42
Very low correlation to market moves
52W High
$164.28
31% below the year high
52W Low
$103.23
10% above the year low
Avg Volume
514,968
Average daily shares traded — higher means easier to buy and sell
3.3
Days it would take all short sellers to cover — higher means more crowded
Short % Float
3.3%
Low short interest — limited bearish positioning
164.0%
Annual dividend as a percentage of the share price
$5.85
Earnings per share over the last 12 months
Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

53.72
Heavy leverage — higher financial risk if revenues decline
1.66
Healthy liquidity position
Quick Ratio
1.01
Like current ratio but excludes inventory — stricter test
Gross Margin
36.7%
Revenue left after cost of goods — higher means pricing power
Operating Margin
11.1%
Profit from core operations before interest and tax
$253M
Positive — the business generates more cash than it spends
Revenue (TTM)
$3.9B
Total revenue over the last 12 months
Net Income
$387M
Profitable — the bottom line is positive
Analyst Coverage
Analysts
7
Target High
$220.00
Target Median
$156.00
Target Low
$145.00
Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry (292 articles) Indicators Join Free →

Get our weekly market brief free.